ACA Orphan Drug Interpretive Rule Oversteps Agency’s Powers, Judge Says
WASHINGTON, D.C. — An agency’s interpretive rule involving orphan drugs and price-cap regulations exceeds statutory power granted to it by the Patient Protection and Affordable Care Act (ACA), a federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article